The American Diabetes Association (ADA) guidelines emphasize the importance of glycemic control during the postpartum period but do not specifically address tirzepatide use during breastfeeding due to insufficient evidence
The FDA approves specific finished drug products, such as: Ozempic (semaglutide injection for diabetes) Wegovy (semaglutide injection for weight management) Mounjaro (tirzepatide injection for diabetes) Zepbound (tirzepatide injection for weight management) Compounded medications: Are not FDA approved, even if they use an FDA-approved ingredient or the same API Do not undergo the same large, branded clinical trials as commercial products Are regulated differentlythrough oversight of the pharmacys practices, not approval of each batch as a drug product This does not automatically mean they are unsafe, but it does mean that pharmacy quality is critical
Frequently Asked Questions Can biotin reduce hair loss caused by semaglutide
Ozempic and similar drugs are not recommended for use in pregnancy, but stopping the medications before conception may also come with some risks, new data suggest
Almost all prescription drug coverage is contingent on the drug being taken for an FDA-approved condition
Pre-treatment screening includes assessment of personal or family history of medullary thyroid cancer and multiple endocrine neoplasia type 2, contraindications to GLP-1 use
